No description available.

Thesis advisor: Anthony T. Annunziato / Thesis advisor: Charles Hoffman / The Hat1 complex was characterized in <italic>S. pombe</italic>. Through tandem affinity purification and mass spectrometry, it was determined that Hat1 is associated with Mis16 (an orthologue of HAT2). Unlike HAT2 in <italic>S. cerevisiae</italic>, we confirm <italic>mis16</italic> to be an essential gene in <italic>S. pombe</italic>. As expected, the <italic>S. pombe</italic> Hat1 complex was found to acetylate lysines 5 and 12 of histone H4. In contrast to budding yeast, deletion of <italic>hat1</italic> alone resulted in the loss of telomeric silencing without concomitant mutations of the H3 N-terminal domain. Deletion of <italic>hat1</italic> caused an increase of H4 acetylation at telomeres. Additionally, the hyperacetylation of histones also results in the loss of telomeric silencing. Loss of Hat1 did not affect silencing at the inner most repeat (imr) or outer repeat (otr) regions of the centromere, but did appear to increase silencing at the central core region (cnt) of the centromere. The experiments described herein demonstrate Hat1 to be essential for the establishment of proper telomeric silencing in fission yeast, and suggest that the timely acetylation of H4 during chromatin assembly is a unique factor in generating the correct epigenetic state at telomeres in <italic>S. pombe</italic>. Additionally, Hat1 and its acetylation of new H4 may have entirely different roles during telomeric silencing than during silencing at the centromeric central core. Our studies in HeLa cells demonstrated that transcription is involved in the exchange of H2A/H2B in acetylated chromatin regions. The finding that cytosolic H2A can be acetylated at lysine 5 is the first demonstration that cytosolic H2A can be specifically modified <italic>in vivo</italic>. Our results support a model in which H2A/H2B exchange during transcription is mediated by the NAP1 chaperone. / Thesis (PhD) — Boston College, 2009. / Submitted to: Boston College. Graduate School of Arts and Sciences. / Discipline: Biology.

Thesis (M.S.)--Michigan State University. Dept. of Biochemistry and Molecular Biology, 2006. / Title from PDF t.p. (viewed on Nov. 20, 2008) Includes bibliographical references (p. 100-101). Also issued in print.

Thesis (M.Med.Sc.)--University of Hong Kong, 2004. / Also available in print.

Epigenetic mechanisms play tremendous roles in the development and management of neural processing. The important mechanisms include inactivation of transcription via methylation, histone modification via acetylation/deacetylation, and miRNA regulation. These modifications allow for expression or silencing of genes, without manipulation of nucleotide sequence. An individual's internal and external environments provide input for quotidian epigenetic regulation. Aberrations in the form of regulation have been increasingly linked to neurological disorders, in addition to the established correlation to tumorigenesis. In recent years, deviations from normal epigenetic patterns have been observed in cases of Alzheimer's disease (AD). The brains of patients with AD have been shown to display significantly less methylation overall, as compared to age-matched controls. Of particular concern, the methylation, which normally keeps the promoter of the APP gene silenced, occur far less frequently in AD patient allowing for the progression of amyloid deposition and subsequent tau pathology. In addition to the hypomethylation present in AD, many AD cases present with a concurrent hypoacetylation on histones in the hippocampus. There is strong evidence suggesting that the reduced levels of acetylation are due to over-activation of histone deacetylases. Post-mortem examinations of the brains of AD patients have shown that the brain-derived neurotrophic gene, which is crucial for neural processing associated with maturation and memory, has low levels of acetylation halting its transcription. While low levels of methylation and acetylation seem to contribute to the pathogenesis of AD, regulatory miRNA levels can have adverse effects whether they are aberrantly reduced or increased. Patients with AD tend to show abnormally augmented expression of miRNA-125b, miRNA-128, and miRNA-9 in the hippocampus, while a reduced expression of miRNA-107. Deregulation of these miRNAs have been linked to the progression of AD and include amyloid deposition, tau pathology, and oxidative stress through inflammatory processes. The latter quandary of oxidative stress has been shown to be crucial for the early progression of AD. Reactive oxygen species disallow the methylation of genes due to steric hindrance at the CpG islands of DNA where DNA methyltransferases act. Research shows that increases in oxidative stress are correlated to decreases in methylation, which allows for APP expression. While these alterations to normal epigenetic patterns occur internally, there is a breadth of changes that the external environment imposes to exacerbated AD pathogenesis. Most heavily studied of these external environmental factors is lead exposure. There is a strong correlation between lead exposure in individuals who carry the ApoE4 gene and increased mRNA transcription of the APP gene. Lead is thought to demethylate the promoter of the APP gene and allow for amyloid processes to occur. Inadequate nutrition, specifically deficits in choline and folate, has been linked to hypomethylated states due to an inefficient "methylation/remethylation cycle" leading to an accumulation of homocysteine characteristic of AD. With the emphasis epigenetic deregulation has in the progression of AD, epigenetic treatments need to be seriously considered as therapeutic avenues. Current drugs treat the symptoms and acute conditions of AD, but through epigenetic modifications, the pathology of the diseases can be directly addressed. Potential therapeutic avenues include the use of methyl donors, highly specific histone deacetylase inhibitors, and miRNA biomarkers. Methyl donors can help alleviate the hypomethylated state and prevent further APP expression and amyloid deposition. Currently, the histone deacetylase inhibitors are being used as global inhibitors, but have adverse effects including non-specific and premature cell death. By further researching these inhibitors and finding a mechanism to attack specific histone deacetylases (such as HDAC6 in AD), the efficacy of this aspect of treatment will be greatly increased. The current use of miRNAs as epigenetic regulators to turn off unwanted genetic expression is ineffective due to a major problem of effective delivery to target zones. By using the gene sequences of miRNAs as biomarkers, an AD patient's genomic sequence can be mapped, marking which areas require regulation. This process is necessary because of the inter-individuality of miRNA regulation between each case of AD. Also, the problem of some anti-miRNA molecules not being able to cross the blood brain barrier needs to be addressed using a novel transport mechanism, as direct brain injections are not feasible. The simplest, and highly effective, therapeutic avenue is a healthy lifestyle. Daily exercise and proper nutrition hinder inflammatory process and oxidative stress and can prevent progression of AD through allowing higher brain perfusion for cognitive functioning.

Un xénobiotique subit plusieurs étapes de biotransformations simultanées ou successives dont les principaux sites sont les tissus situés à l’interface entre l’organisme et le milieu extérieur, à savoir : le tube digestif, l’appareil respiratoire, le rein et le foie. Ce dernier étant fonctionnellement le plus important. Les phases réactionnelles principales constituant les étapes de détoxification, phase I, phase II et phase III, ne sont possibles que par l'intervention de systèmes enzymatiques spécifiques. Etant donné la grande diversité des xénobiotiques auxquels l'organisme est exposé, il existe une multitude d'enzymes présentant des spécificités variées. Les réactions de biotransformation des xénobiotiques s'enchaînent rarement de façon linéaire, car deux voies ou plus prennent souvent naissance à partir d'un métabolite donné. On comprend dès lors que l'existence d'un variant enzymatique défectif pour l'une de ces voies réactionnelles pourra orienter le métabolisme d'une substance donnée vers une autre voie. Cette dernière, généralement mineure, prendra donc une grande importance et les polymorphismes qui la concernent pourront orienter le devenir des métabolites ainsi formés. La famille des N-acétyltransférases (NATs) fait partie des enzymes assurant principalement la réaction de conjugaison de la phase II de détoxification des xénobiotiques. Le polymorphisme des NATS représente l'un des exemples de variation pharmacogénétique décrit, et de l'un des plus documentés, depuis sa découverte au début des années 50, en même temps que la découverte de la grande efficacité de l’isoniazide (INH) dans le traitement de la tuberculose.Les travaux de cette thèse avaient pour objectif d’étudier le profil d’acétylation de la NAT2 dans la population sénégalaise afin de les répartir en acétyleurs lents et en acétyleurs rapides, et de déterminer la cinétique de l’isoniazide chez des sujets tuberculeux en corrélation avec les résultats de génotypage. L’étude des mutations du gène NAT2 a été effectuée par PCR-séquençage directe et a permis de mettre en évidence 11 variants alléliques dans la population sénégalaise.l’activité enzymatique de la NAT2 a été déterminée par utilisation du test à la caféine et le rapport des ratios des métabolites majeurs a permis classer les sénégalais en acétyleurs lents et rapides. La cinétique de l’isoniazide a utilisée la chromatographie UPLC-MS/MS. Ce travail présente les premiers résultats de l’étude de la NAT2 dans la population sénégalaise qui pourront être utilisés pour une meilleur optimisation de l’utilisation de l’INH dans la prise en charge de la tuberculose, maladie à forte prévalence en Afrique. / Xenobiotic biotransformation undergoes several stages of simultaneous or successive whose main attractions are the tissues at the interface between the organism and the external environment, namely: digestive, respiratory, kidney and liver. The latter being the most important functionally. The reaction phases constituting the main stages of detoxification, phase I, phase II and phase III, are possible only through the intervention of specific enzyme systems. Given the wide diversity of xenobiotics to which the organism is exposed, there are a multitude of enzymes with various specificities. The biotransformation reactions of xenobiotics are linked linearly rarely, because two or more lanes are often born from a given metabolite. It is therefore understandable that the existence of an enzyme variant defective for one of these reaction pathways can direct the metabolism of a given substance to another track. The latter, usually minor, will therefore important and polymorphisms that concern will guide the fate of metabolites thus formed. The N-acetyltransferases (NATs) is part of enzymes that primarily the conjugation reaction of phase II detoxification of xenobiotics. The polymorphism of NATS is one of the examples of pharmacogenetic variation described, and one of the most documented since its discovery in the early \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'50s, along with the discovery of the high efficacy of isoniazid (INH) in the treatment of tuberculosis. The work of this thesis aimed to study the profile of the NAT2 acetylation in the Senegalese population in order to distribute them in slow acetylators and rapid acetylators, and determine the kinetics of isoniazid in tuberculous subjects correlated with the results of genotyping. The study of mutations of the NAT2 gene was performed by PCR-direct sequencing and allowed to identify 11 allelic variants in the Senegalese population. The enzymatic activity of NAT2 was determined by using caffeine test and the ratios of major metabolites allowed Senegalese classify fast and slow acetylators. The kinetics of isoniazid used UPLC-MS/MS chromatography.

Thesis advisor: Anthony T. Annunziato / The project I am presenting aimed to: 1. Elucidate the pattern of post- translational modification on the different variants of newly synthesized histones H3 in mammalian cells; 2. Reveal whether the acetylation of residue K56 on newly synthesized H3 histones plays a role in the incorporation of the histone into chromatin in mammalian cells; and 3. Determine whether the acetylation of residue K56 on newly synthesized H3 histones plays a role in the incorporation of the histone specifically in replicating chromatin in mammalian cells. The experiments to answer these questions were performed using HEK293 cells with inducible expression of FLAG-histones, enabling us to control the synthesis of new histones of interest and to detect and analyze their presence and relative levels in the cells. The results suggest that the acetylation of lysine 56 on histone H3 may play a positive role in the incorporation of the histone into new chromatin, and lack of acetylation may be reducing the efficiency of incorporation compared to acetylated histones. / Thesis (MS) — Boston College, 2010. / Submitted to: Boston College. Graduate School of Arts and Sciences. / Discipline: Biology.

Lysine acetylation is a post-translational modification (PTM) studied extensively in the context of histone proteins as a regulator of chromatin dynamics. Recent proteomic studies have revealed that as much as 10% of prokaryotic and mammalian proteins undergo lysine acetylation, and as such, the study of its biological consequences is rapidly expanding to include virtually all cellular processes. Unravelling the complex regulatory network governed by lysine acetylation will require an in depth knowledge of the lysine acetyltransferase enzymes that mediate catalysis, and moreover the development of methods that can identify enzyme-substrate relationships in vivo. This is complex task and will be aided significantly through the use of model organisms and systems biology approaches. The work presented in this thesis explores the function of the highly conserved NuA4 lysine acetyltransferase enzyme complex in the model organism Saccharomyces cerevisiae using systems biology approaches. By exploiting genetic screening tools available to the budding yeast model, I have systematically assessed the cellular roles of NuA4, thereby identifying novel cellular processes impacted by the function of the complex, such as vesicle-mediated transport and the stress response, and moreover identified specific pathways and proteins that are impacted by NuA4 KAT activity, including cytokinesis through the regulation of septin protein dynamics. Moreover, I have developed a mass spectrometry-based technique to identify NuA4-dependent acetylation sites amongst proteins that physically interact with NuA4 in vivo. Together this work demonstrates the diversity of processes impacted by NuA4 function in vivo and moreover highlights the utility of global screening techniques to characterize KAT function.

Lysine acetylation is a post-translational modification (PTM) studied extensively in the context of histone proteins as a regulator of chromatin dynamics. Recent proteomic studies have revealed that as much as 10% of prokaryotic and mammalian proteins undergo lysine acetylation, and as such, the study of its biological consequences is rapidly expanding to include virtually all cellular processes. Unravelling the complex regulatory network governed by lysine acetylation will require an in depth knowledge of the lysine acetyltransferase enzymes that mediate catalysis, and moreover the development of methods that can identify enzyme-substrate relationships in vivo. This is complex task and will be aided significantly through the use of model organisms and systems biology approaches. The work presented in this thesis explores the function of the highly conserved NuA4 lysine acetyltransferase enzyme complex in the model organism Saccharomyces cerevisiae using systems biology approaches. By exploiting genetic screening tools available to the budding yeast model, I have systematically assessed the cellular roles of NuA4, thereby identifying novel cellular processes impacted by the function of the complex, such as vesicle-mediated transport and the stress response, and moreover identified specific pathways and proteins that are impacted by NuA4 KAT activity, including cytokinesis through the regulation of septin protein dynamics. Moreover, I have developed a mass spectrometry-based technique to identify NuA4-dependent acetylation sites amongst proteins that physically interact with NuA4 in vivo. Together this work demonstrates the diversity of processes impacted by NuA4 function in vivo and moreover highlights the utility of global screening techniques to characterize KAT function.

Bacterial biofilms form on liquid/air and liquid/solid surfaces and consist of cells combined with an extracellular matrix such as exopolysaccharides, extracellular DNA, and glycoproteins. Bacteria have up to a 1000-fold increase of antibiotic resistance in biofilms compared to planktonic cells. Furthermore, biofilm cells show better tolerance to adverse environmental conditions such as nutrition limitations, temperature changes, pH changes, and non-optimal osmotic conditions. In Escherichia coli, the outer membrane protein OmpA increased biofilm formation on polystyrene, polypropylene, and polyvinyl chloride surfaces while it decreased biofilm formation on glass surfaces. This surface-dependent phenotype was because OmpA inhibits cellulose production by inducing the CpxRA two-component signal transduction pathway, and cellulose inhibits biofilm formation on plastic due to its hydrophilic nature. We discovered, and then engineered, BdcA (formerly YjgI), for biofilm dispersal. We found that in E. coli, BdcA increases motility and extracellular DNA production while it decreases exopolysaccharide production, cell length, and aggregation. We reasoned that the 3, 5-cyclic diguanylic acid (c-di-GMP) levels increase upon deleting bdcA, and showed that BdcA binds c-di-GMP in vitro. In addition, we used protein engineering to evolve BdcA for greater c-di-GMP binding and found that the single amino acid change E50Q causes nearly complete biofilm dispersal. We isolated Proteus mirabilis from the blowfly Lucilia sericata, which swarmed significantly. By motility screening and complementation with putative interkingdom signal molecules that have been shown to attract flies, we found lactic acid, phenol, NaOH, KOH, putrescine, and ammonia restore the swarming motility of seven different swarming deficient mutants. These mutants and putative signal molecules will be further tested for fly attraction and oviposition. Acetylation of lysine residues is conserved in all three kingdoms although its role in bacteria is not clear. We demonstrated that acetylation enables E. coli to withstand environmental stresses. Specifically, the bacteria became more resistant to heat and oxidative stress. Furthermore, we showed that the increase in oxidative stress resistance is due to the induction of catalase gene katG. Hence we demonstrate for the first time a specific physiological role for acetylation in prokaryotes.